Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 141.13% | 168.35% | 170.15% | -1,602.50% | -524.16% |
| Total Depreciation and Amortization | 96.89% | 128.26% | 39.87% | -6.08% | -42.46% |
| Total Amortization of Deferred Charges | 77.26% | 117.56% | 119.79% | 149.92% | 180.00% |
| Total Other Non-Cash Items | -159.87% | -179.54% | -179.45% | 1,882.11% | 951.46% |
| Change in Net Operating Assets | 1,693.09% | 372.35% | 7.62% | -76.13% | -93.30% |
| Cash from Operations | 49.45% | 25.07% | -12.05% | -98.63% | -123.41% |
| Capital Expenditure | -53.07% | -85.32% | -447.80% | -562.71% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.99% | 21.26% | -707.02% | -- | -- |
| Cash from Investing | 85.70% | 0.64% | -614.19% | -4,876.27% | -- |
| Total Debt Issued | -53.43% | -31.33% | 21.81% | 140.23% | 203.68% |
| Total Debt Repaid | -84.93% | -17.63% | -30.82% | -63.02% | -25.59% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 676.00% | -- | -100.00% |
| Cash from Financing | -57.21% | -24.44% | 32.83% | 140.83% | 162.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.78% | -440.54% | 188.89% | -- | -- |